Results 111 to 120 of about 13,977 (219)

Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.

Journal of Clinical Endocrinology and Metabolism, 2006
D. Perrien, S. Achenbach, Samuel E. Bledsoe, Brandon Walser, L. Suva, S. Khosla, D. Gaddy   +6 more
semanticscholar   +1 more source

Pathophysiology and Treatment of Pulmonary Arterial Hypertension. [PDF]

Int J Mol Sci
Fukumoto Y.
europepmc   +1 more source

Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism.

Endocrinology, 2023
Kappes EC, Kattamuri C, Czepnik M, Yarawsky AE, Brûlé E, Wang Y, Ongaro L, Herr AB, Walton KL, Bernard DJ, Thompson TB.   +10 more
europepmc   +1 more source

Loss of Inhibin Negative Feedback to Pituitary Gonadotropes Leads to Enhanced Ovulation but Pregnancy Failure in Mice.

Endocrinology
Lin YF, Brûlé E, Ongaro L, Zhou X, Jin Y, Schultz H, Cowan M, Stouffer DG, Yaman A, Auchus RJ, Boehm U, Bernard DJ.   +11 more
europepmc   +1 more source

Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.

Journal of Endocrinology, 2003
T. Vanttinen, J. Liu, T. Kuulasmaa, P. Kivinen, R. Voutilainen   +4 more
semanticscholar   +1 more source

Activin Actions in Adipocytes.

J Clin Endocrinol Metab
Ongaro L, Bernard DJ.
europepmc   +1 more source

Potential role of kisspeptin in the estradiol-induced modulation of inhibin subunit gene expression: Insights from in vivo rat models and hypothalamic cell models. [PDF]

Endocr J
Tumurbaatar T, Kanasaki H, Cairang Z, Lkhagvajav B, Oride A, Okada H, Kyo S.   +6 more
europepmc   +1 more source

Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention. [PDF]

Cancer Genomics Proteomics
Graziano S, Höllbacher B, Weidle UH.
europepmc   +1 more source

Fertility Protection in Female Cancer Patients: From Molecular Mechanisms of Gonadotoxic Therapies to Pharmacotherapeutic Possibilities. [PDF]

Int J Mol Sci
Zajączkowska W, Buda M, Kędzia W, Kapczuk K.   +3 more
europepmc   +1 more source